Literature DB >> 12168921

The natural history of HPV infection of the uterine cervix. Long-term observational and histological data.

Evangelos Paraskevaidis1, Apostolos Kaponis, Vassiliki Malamou-Mitsi, Emma J Davidson, Pierre Martin Hirsch, George Koliopoulos, Lina Papp, Konstantinos Zikopoulos, Minas Paschopoulos, Evangelos Lolis, Panagiotis Stamatopoulos, Niki J Agnantis.   

Abstract

BACKGROUND: To investigate the natural history of HPV infection of the uterine cervix following a 10-year prospective observational study. PATIENTS AND METHODS: Three hundred and thirty women with cytological and colposcopic features of HPV infection +/- CIN 1 were recruited into the study. These women were followed up for a period of 10 years, during which time they had repeated colposcopic assessments and cytological monitoring Those women with evidence of high-grade disease at any stage of follow-up were treated by Large Loop excision of the transformation zone (LLETZ) and excluded from the study. At the end of the surveillance period, 179 women with evidence of persistent HPV infection alone or in conjunction with low-grade disease underwent a shallow diagnostic LLETZ. In total, 51 women defaulted from follow-up.
RESULTS: Thirty-three per cent of the women with cytological and colposcopic features suggestive of persistent HPV infection alone during the 10-year follow-up period had histological evidence of CIN at the end of the study. Two thirds of this disease was graded as CIN 2 or 3. Nineteen per cent of the women with cytological and colposcopic features suggestive of persistent HPV infection and CIN 1 actually had high-grade CIN at histology (CIN 2 and 3). Only 6.1% of the study population had normal histological findings.
CONCLUSION: The finding that a relatively large percentage of high-grade lesions might have been masked for anything up to a decade by a low-grade phenotype, coupled with the worrying percentage of defaulters from follow-up, indicate that an early decision for intervention (diagnostic and/or therapeutic) may be appropriate if a low-grade abnormality persists after a short surveillance period.

Entities:  

Mesh:

Year:  2002        PMID: 12168921

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

Review 1.  Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.

Authors:  Maria Kyrgiou; Ilkka E J Kalliala; Anita Mitra; Christina Fotopoulou; Sadaf Ghaem-Maghami; Pierre Pl Martin-Hirsch; Margaret Cruickshank; Marc Arbyn; Evangelos Paraskevaidis
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

2.  Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union.

Authors:  Stina Syrjänen; Irena Shabalova; Nicolay Petrovichev; Vladimir Kozachenko; Tatjana Zakharova; Julia Pajanidi; Jurij Podistov; Galina Chemeris; Larisa Sozaeva; Elena Lipova; Irena Tsidaeva; Olga Ivanchenko; Alla Pshepurko; Sergej Zakharenko; Raisa Nerovjna; Ludmila Kljukina; Oksana Erokhina; Marina Branovskaja; Maritta Nikitina; Valerija Grunberga; Alexandr Grunberg; Anna Juschenko; Piero Tosi; Marcella Cintorino; Rosa Santopietro; Kari Syrjänen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 3.  Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.

Authors:  Jill Koshiol; Lisa Lindsay; Jeanne M Pimenta; Charles Poole; David Jenkins; Jennifer S Smith
Journal:  Am J Epidemiol       Date:  2008-05-15       Impact factor: 4.897

4.  Identification of women for referral to colposcopy by neural networks: a preliminary study based on LBC and molecular biomarkers.

Authors:  Petros Karakitsos; Charalampos Chrelias; Abraham Pouliakis; George Koliopoulos; Aris Spathis; Maria Kyrgiou; Christos Meristoudis; Aikaterini Chranioti; Christine Kottaridi; George Valasoulis; Ioannis Panayiotides; Evangelos Paraskevaidis
Journal:  J Biomed Biotechnol       Date:  2012-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.